Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
IPXL > SEC Filings for IPXL > Form 8-K on 2-Apr-2014All Recent SEC Filings

Show all filings for IMPAX LABORATORIES INC

Form 8-K for IMPAX LABORATORIES INC


2-Apr-2014

Change in Directors or Principal Officers, Financial Statements and Exhibi


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 1, 2014, Impax Laboratories, Inc. entered into an amendment to the employment agreement with each of Bryan Reasons, Michael Nestor, Carole Ben-Maimon, M.D., and Mark Schlossberg (collectively, the "Amendments"). The Amendments provide that a written notice of non-renewal of the term of such employment agreement will constitute good reason for such executive to resign and be eligible to receive severance benefits under the employment agreement.

The foregoing is a summary description of the terms and conditions of the Amendments and is qualified in its entirety by the text of the Amendments, which are attached hereto as Exhibits10.1, 10.2, 10.3 and 10.4 and incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

The following exhibits are filed herewith.

Exhibit No.   Description
              Amendment dated as of April 1, 2014 to the Employment Agreement
   10.1       dated as of December 12, 2012 by and between Impax Laboratories,
              Inc. and Bryan Reasons.
              Amendment dated as of April 1, 2014 to the Employment Agreement
   10.2       dated as of January 1, 2010 by and between Impax Laboratories, Inc.
              and Michael Nestor.
              Amendment dated as of April 1, 2014 to the Employment Agreement
   10.3       dated as of November 7, 2011 by and between Impax Laboratories,
              Inc. and Carole Ben-Maimon, M.D.
              Amendment dated as of April 1, 2014 to the Employment Agreement
   10.4       dated as of May 2, 2011 by and between Impax Laboratories, Inc. and
              Mark Schlossberg.


  Add IPXL to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for IPXL - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.